Osteal Therapeutics, Inc. filed a Form D with the Securities and Exchange Commission on 2025-11-05.
Osteal Therapeutics, Inc. filed a Form D notice of an exempt securities offering with the SEC on November 5, 2025. The filing reports $15.60M sold. Its industry group is Pharmaceuticals. It names David Thompson (Executive Officer, Director), Erik Oros (Director), Sonal Patel (Director) (SEC Form D, November 5, 2025).
Is this your company?
Sell to companies like Osteal Therapeutics, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-11-05 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Osteal Therapeutics, Inc.
Free to see. No signup.
More on the people and the money behind Osteal Therapeutics, Inc., from the filings we hold.
Pharmaceuticals raises by companies based in Texas, filed within 90 days of this one, largest first.
Get an email when Osteal Therapeutics, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Osteal Therapeutics, Inc. raises, hires or launches. No email unless you switch it on.
Watch Osteal Therapeutics, Inc. →Get the full cited report on Osteal Therapeutics, Inc.
What the filing shows about Osteal Therapeutics, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Osteal Therapeutics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Osteal Therapeutics, Inc.'s address as 4835 Lyndon B. Johnson Fwy Ste 635, Dallas, TX 75244.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on Osteal Therapeutics, Inc. See pricing
Osteal Therapeutics, Inc. is a registered filer with the SEC (CIK 1735936) and has filed since 2023-09-12. 3 filings are on record, the latest on 2025-11-05.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Osteal Therapeutics, Inc.'s Form D of 2025-11-05 names David Thompson, Erik Oros, Sonal Patel and 7 more as its officers, directors or promoters.
Its new offerings report $87.89M sold across 3 offerings, as its own filings state.
Each marker is one filing. The larger marker is the filing this page is about.
Trailing twelve months. 155 filings in Pharmaceuticals, totalled by week. The dot is this raise, $15.60M, on the same scale — one filing against the whole group's total, so it sits low by construction.
David Thompson is named as Executive Officer and Director on the Form D that Osteal Therapeutics, Inc. filed with the SEC on 5 November 2025, one of 10 people that filing names.
Erik Oros is named as Director on the Form D that Osteal Therapeutics, Inc. filed with the SEC on 5 November 2025, one of 10 people that filing names.
Sonal Patel is named as Director on the Form D that Osteal Therapeutics, Inc. filed with the SEC on 5 November 2025, one of 10 people that filing names.
Martin Sands is named as Director on the Form D that Osteal Therapeutics, Inc. filed with the SEC on 5 November 2025, one of 10 people that filing names.
Rushu Luo is named as Director on the Form D that Osteal Therapeutics, Inc. filed with the SEC on 5 November 2025, one of 10 people that filing names.
Judson Cooper is named as Director on the Form D that Osteal Therapeutics, Inc. filed with the SEC on 5 November 2025, one of 10 people that filing names.
Biren Mehta is named as Director on the Form D that Osteal Therapeutics, Inc. filed with the SEC on 5 November 2025, one of 10 people that filing names.
David Cash is named as Director on the Form D that Osteal Therapeutics, Inc. filed with the SEC on 5 November 2025, one of 10 people that filing names.
Brian de Beaubien is named as Executive Officer and Director on the Form D that Osteal Therapeutics, Inc. filed with the SEC on 5 November 2025, one of 10 people that filing names.
Douglas Kohrs is named as Director on the Form D that Osteal Therapeutics, Inc. filed with the SEC on 5 November 2025, one of 10 people that filing names.
10 people named on the filing — 2 holding an executive role and 8 as directors only.
Named as of the 2025-11-05 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Osteal Therapeutics, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Osteal Therapeutics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Osteal Therapeutics, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Osteal Therapeutics, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Osteal Therapeutics, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Osteal Therapeutics, Inc.. With no account yet, you sign up free and land on the result.
On these lists: Pharmaceuticals raises in Dallas-Fort Worth
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/osteal-therapeutics-inc-form-d-25000001